This course is part of the MCO Leadership New Session Review curriculum.
Podcast
Reflux Reflections: A Comprehensive Approach to Management of GERD
View full Pharmacology Updates CME/CE Package.
Gastroesophageal reflux disease (GERD) is a frequent issue in primary care, affecting millions of patients each year. This high-pharmacology credit podcast explores the pathophysiology and common presentation of GERD to help clinicians better understand the mechanisms behind pharmacologic treatments. Learn how to evaluate the risks and benefits of H2 blockers versus proton-pump inhibitors, focusing on side effect profiles, and apply the latest evidence-based guidelines for managing GERD effectively in your practice. A must-listen for PCPs aiming to improve care for this widespread condition.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 5/7/2025
Expiration Date: 6/15/2026
Topics
Learning Objectives
- Explain the pathophysiology and common presentation of gastro-esophageal reflux disease (GERD) in order to understand the mechanism of action of pharmacologic treatment
- Compare the risks and benefits of H2 blockers and proton-pump inhibitors as management for GERD, focusing on common side effects
- Apply current, evidence-based, guidelines and treatments for GERD to effectively manage the condition in primary care settings
Faculty
Danielle Hebert, DNP, MBA, ANP-BC
Assistant Professor and Coordinator AGPCNP Track
University of Massachusetts Chan Medical School
Tan Chingfen Graduate School of Nursing
Worcester, MA
Disclosures
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Danielle Hebert, DNP, MBA, ANP-BC: No relevant financial relationships disclosed
Non-faculty contributors and others involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.